Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Cash & Current Investments (2016 - 2025)

Kiora Pharmaceuticals' Cash & Current Investments history spans 11 years, with the latest figure at $17.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 36.2% year-over-year to $17.1 million; the TTM value through Dec 2025 reached $17.1 million, down 36.2%, while the annual FY2025 figure was $17.1 million, 36.2% down from the prior year.
  • Cash & Current Investments reached $17.1 million in Q4 2025 per KPRX's latest filing, down from $19.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $31.3 million in Q1 2024 to a low of $2.5 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $13.5 million, with a median of $8.0 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: tumbled 56.5% in 2022, then surged 989.57% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $7.9 million in 2021, then crashed by 38.6% to $4.9 million in 2022, then plummeted by 49.31% to $2.5 million in 2023, then soared by 989.57% to $26.8 million in 2024, then crashed by 36.2% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Cash & Current Investments are $17.1 million (Q4 2025), $19.4 million (Q3 2025), and $20.7 million (Q2 2025).